Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery

NCT ID: NCT05931783

Last Updated: 2024-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-12

Study Completion Date

2031-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Internal thoracic arteries can be harvested in skeletonized or pedicled technique. Latest research has posed a potential adverse effect of skeletonizing the internal thoracic arteries on graft patency rates and clinical outcome. Prospective, randomized, multi-centre trials are necessary to investigate the impact of harvesting technique of left internal thoracic artery (LITA) on graft patency rates and clinical outcome after coronary artery bypass grafting.

The HARVITA trial compares skeletonized and pedicled harvesting technique of LITA regarding graft patency rates and patient survival.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

skeletonized harvesting technique

In skeletonized harvesting technique, only the left internal artery itself is harvested.

Group Type ACTIVE_COMPARATOR

skeletonized harvesting technique

Intervention Type PROCEDURE

In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in skeletonized technique. Thereby, only the artery itself is harvested.

pedicled harvesting technique

In pedicled harvesting technique the left internal thoracic artery, it's accompanying veins and parts of the endothoracic fascia is harvested, creating a 1-2 cm broad pedicle.

Group Type ACTIVE_COMPARATOR

pedicled harvesting technique

Intervention Type PROCEDURE

In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in pedicled technique. Thereby, the artery will be harvested together with the accompanying veins, the endothoracic fascia and fatty tissue in order to create an 1-2 cm broad pedicle.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

skeletonized harvesting technique

In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in skeletonized technique. Thereby, only the artery itself is harvested.

Intervention Type PROCEDURE

pedicled harvesting technique

In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in pedicled technique. Thereby, the artery will be harvested together with the accompanying veins, the endothoracic fascia and fatty tissue in order to create an 1-2 cm broad pedicle.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of the left anterior descending artery (LAD) and ≥50% stenosis of circumflex and right coronary territory, with or without a ≥50% stenosis of the left main artery).

Exclusion Criteria

* Age \> 80 years
* Planned CABG without LITA use
* Preoperative mediastinal radiation therapy
* Emergency operation
* Minimal invasive coronary artery bypass surgery
* Any concomitant cardiac or non-cardiac procedures
* Previous cardiac surgery
* Known contrast agent allergy
* Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome
* Chronic kidney disease (GFR \<60ml/min/1.73m²)
* Life expectancy of less than 5 years
* Pregnancy
* Hyperthyroidism
* Iodine allergy


* Y/T graft off the LITA graft
* LITA sequential grafting
* LITA target vessel other than LAD
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University Innsbruck

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hannes Abfalterer, Dr. med. univ.

Role: PRINCIPAL_INVESTIGATOR

Medical University Innsbruck

Nikolaos Bonaros, Univ. Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Medical University Innsbruck

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Graz

Graz, , Austria

Site Status NOT_YET_RECRUITING

Medical University of Innsbruck

Innsbruck, , Austria

Site Status RECRUITING

Medical University of Vienna

Vienna, , Austria

Site Status NOT_YET_RECRUITING

University of Duisburg-Essen

Essen, , Germany

Site Status NOT_YET_RECRUITING

University of Freiburg

Freiburg im Breisgau, , Germany

Site Status NOT_YET_RECRUITING

University Hospital Gießen

Giessen, , Germany

Site Status NOT_YET_RECRUITING

University of Jena

Jena, , Germany

Site Status NOT_YET_RECRUITING

University Hospital Bern

Bern, , Switzerland

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria Germany Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hannes Abfalterer, Dr. med. univ.

Role: CONTACT

004351250482988

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Daniel Zimpfer, Univ. Prof. Dr.

Role: primary

Hannes Abfalterer, Dr. med. univ.

Role: primary

Sigrid Sandner, Assoz. Prof. Priv. Doz. Dr.

Role: primary

Matthias Thielmann, Univ. Prof. Dr.

Role: primary

Martin Czerny, Univ. Prof. Dr.

Role: primary

Andreas Böning, Univ. Prof. Dr.

Role: primary

Torsten Doenst, Univ. Prof. Dr.

Role: primary

Matthias Siepe, Univ. Prof. Dr.

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Lamy A, Browne A, Sheth T, Zheng Z, Dagenais F, Noiseux N, Chen X, Bakaeen FG, Brtko M, Stevens LM, Alboom M, Lee SF, Copland I, Salim Y, Eikelboom J; COMPASS Investigators. Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery: A Post Hoc Analysis From the COMPASS Trial. JAMA Cardiol. 2021 Sep 1;6(9):1042-1049. doi: 10.1001/jamacardio.2021.1686.

Reference Type BACKGROUND
PMID: 34132753 (View on PubMed)

Gaudino M, Audisio K, Rahouma M, Chadow D, Cancelli G, Soletti GJ, Gray A, Lees B, Gerry S, Benedetto U, Flather M, Taggart DP; ART Investigators. Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial. JAMA Cardiol. 2021 Dec 1;6(12):1380-1386. doi: 10.1001/jamacardio.2021.3866.

Reference Type BACKGROUND
PMID: 34586338 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1135/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AVERT Plus Post-Market Registry
NCT02436642 TERMINATED